Reza Samavati

Senior pharmacology and preclinical development leader with 15+ years of experience across CRO, biotech, and academic environments. Expert in PK/PD study design and analysis, drug metabolism, toxicology, and translational research. Proven track record directing GLP/non-GLP studies, mentoring scientists, and delivering high-quality scientific reports for regulatory and client-facing purposes. Seeking to contribute expertise in project management, pharmacokinetics, drug metabolism, and study direction to a biotech or pharma organization.

• Attention to detail
• Bilingual communication
• Communication
• Data analysis
• Data entry
• Data visualization
• English
• First Aid
• Inventory management
• Leadership
• Machine learning
• Microsoft Excel
• Microsoft Office
• Microsoft Outlook
• Microsoft Word
• Occupational safety
• Organization
• Problem solving
• Project management
• Quality assurance
• Teamwork
• Time management

1. Senior Study Director / Principal PK & QSP Expert

   CSL Behring

   Sep 2024 to Present

   Marburg, Germany

   • Design, plan, supervise, analyze, and report PK and PK/PD studies for preclinical and clinical programs. • Conduct drug–drug interaction (DDI) investigations and predictions using internal data, literature, and published sources. • Monitor external contracted studies and ensure scientific quality and alignment with project goals. • Provide scientific support for pharmacology studies across preclinical and clinical stages.

2. Study Director, Mammalian Toxicology

   Charles River Laboratories Hungary Kft

   Jul 2022 to Jul 2024

   Veszprém, Hungary

   • Designed, planned, and supervised GLP and non-GLP mammalian toxicology studies, including LLNA, GPMT/Buehler, AOT, ADT, and AET. • Ensured study conduct followed OECD and ISO guidelines and maintained compliance with regulatory standards. • Maintained regular communication with clients throughout study execution and provided timely updates. • Analyzed data, interpreted results, and prepared final study reports for client delivery.

3. Assistant Professor, Department of Pharmacology and Pharmacotherapy

   University of Szeged

   Jan 2017 to Jul 2022

   Szeged, Hungary

   • Developed and applied a new ex vivo method for hepatic drug metabolism studies in male, female, and cross-sex hormone-treated rats. • Contributed to reproductive pharmacology projects and mechanistic studies on smooth muscle physiology (GI tract and uterus). • Trained and supervised PhD students and contributed to scientific training and project execution. • Delivered pharmacology teaching, seminars, practical sessions, and examinations.

4. Research Associate, Opioid Research Group

   Hungarian Academy of Sciences, Biological Research Center, Institute of Biochemistry

   Nov 2012 to Sep 2014

   Szeged, Hungary

   • Investigated the relationship between opioid and NMDA receptor function for pain management in rat brain. • Studied the potential of the opioid system for cancer therapy, including antimetastatic, antiproliferative, and apoptotic effects in mice. • Examined the correlation and co-localization of opioid–cannabinoid receptors in rat and mouse brain. • Evaluated the bioactivity of different bivalent peptides on opioid–cannabinoid receptors in rodents.

5. Research Assistant, Department of Pharmacodynamics and Biopharmacy

   University of Szeged

   Sep 2008 to Jun 2012

   Szeged, Hungary

   • Developed a new method for investigation of uterine contractility in pregnant rats in vivo.

1. University of Szeged

   PhD, Clinical Medicine (Neurology)

   Szeged, Hungary

   2014 to 2017

2. University of Szeged

   Doctor of Pharmacy (PharmD)

   Szeged, Hungary

   2007 to 2012

3. Azad University

   BSc, Biology

   Boroujerd, Iran

   1998 to 2001

• FELASA Category C

  University of Szeged, Department of Surgical Research

• GermanBasic